FDA panel backs much-debated ALS drug in rare, 2nd review

Argentina Noticias Noticias

FDA panel backs much-debated ALS drug in rare, 2nd review
Argentina Últimas Noticias,Argentina Titulares
  • 📰 AP
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 51%

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.

“To deprive ALS patients of a drug that might work, it’s probably not something I would feel terribly comfortable with,” said Dr. Liana Apostolova of Indiana University’s School of Medicine, who voted for approval. “At the previous meeting it wasn’t that clear and it’s still questionable.”

Wednesday’s vote concluded a rare second meeting to review several new statistical analyses submitted by Amylyx in support of the treatment’s benefit in slowing disease and extending life. Dunn also noted that a larger Amylyx study being conducted in the U.S. and Europe could provide “more definitive results” by 2024.

Amylyx conducted one small, mid-stage trial of its drug that showed some benefit in slowing the disease, but it was plagued by missing data and other problems, according to“The final result — for a single study — is borderline and not very statistically persuasive,” FDA statistician Tristan Massie told panelists.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

AP /  🏆 728. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Desperate patients want a new ALS drug. The FDA is not sure it works.Desperate patients want a new ALS drug. The FDA is not sure it works.The therapy is the latest to raise questions about how the FDA assesses drugs for devastating diseases, such as ALS and Alzheimer's.
Leer más »

Does controversy sell movie tickets? The cast of 'Don't Worry Darling' might find outDoes controversy sell movie tickets? The cast of 'Don't Worry Darling' might find outThe premiere of the film Don't Worry Darling at the Venice Film Festival has created new memes and much-debated moments — none of which involve what actually happens onscreen.
Leer más »

Your at-home COVID-19 test may not have expired after allYour at-home COVID-19 test may not have expired after allSome of the expiration dates were extended as the agency received new data that showed the products still worked, according to the FDA. The tests that the federal government sent to people this year now have a 12-month shelf life.
Leer más »

Guy Fieri in Florida: Where to find all 28 restaurants seen on 'Diners, Drive-Ins and Dives'Guy Fieri in Florida: Where to find all 28 restaurants seen on 'Diners, Drive-Ins and Dives'Looking for Flavortown? It might be here. GuyFieri , famous celebrity chef and new Florida resident, seems to love the food in the Sunshine State. (So do we.) Here's where to find his favorites, 28 Florida restaurants already featured on 'Triple D.'
Leer más »



Render Time: 2025-03-09 20:33:06